New Delhi, Sept. 25 -- Lord's Mark Industries Limited, in collaboration with the Centre for Materials for Electronic Technology (C-MET), has improved its AI-powered, radiation-free wearable breast cancer screening technology towards its final clinical trial stage, with trials planned across the USA, Great Britain and Europe. Developed using high-precision thermal sensors and AI-driven temperature mapping, the technology is designed to identify abnormalities associated with breast cancer in a non-invasive and radiation-free manner. The technology has undergone high-accuracy and conformity testing, with Lord's Mark Industries Limited holding rights for its commercialisation. Phase 2 trials for detection of cancer at the cell level, targetin...